ArticleBlood cancer journal2023

Safety and efficacy of CD22 and CD19 CAR-T bridging auto-HSCT as consolidation therapy for AYA and adult B-ALL.

Yan Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.